Dexcom | DXCM - Sales Revenues

Dexcom reported $815.2M in Sales Revenues for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbott ABT:US USD 10.09B 319M
Align Technology ALGN:US USD 901.52M 11.17M
Avanos Medical Inc AVNS:US USD 217.5M 15.4M
Baxter International BAX:US USD 3.89B 114M
Becton, Dickinson and BDX:US USD 4.59B 175M
Boston Scientific BSX:US USD 3.24B 72M
Cardiovascular Systems CSII:US USD 61.45M 1.78M
Dexcom DXCM:US USD 815.2M 45.6M
Edwards Lifesciences EW:US USD 1.35B 29.3M
Hologic HOLX:US USD 1.07B 121M
Inogen INGN:US USD 88.09M 17.3M
Johnson & Johnson JNJ:US USD 23.71B 85M
Sientra SIEN:US USD 22.57M 1.06M
Stryker SYK:US USD 5.2B 723M
West Pharmaceutical Services WST:US USD 708.7M 21.8M
Zimmer Biomet Holdings Inc ZBH:US USD 1.83B 155.3M